METTL14 promotes AML progression by positively regulating the expression of its targets, such as MYB and MYC, through enhancement of their m6A modification, and METTL14 transcription is negatively regulated by SPI1 [69]. This evidence concerns the gene MYC and acute myeloid leukemia.